Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Radiation Oncology Treatment Planning Software Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The radiation oncology treatment planning software market has experienced robust expansion in recent years. Projections indicate its expansion from $2.51 billion in 2025 to $2.74 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 9.1%. Key drivers for this historical growth include an increase in global cancer cases, the wider use of radiation therapy methods, improvements in medical imaging technology, the need for accurate dose administration, and the proliferation of oncology treatment facilities.
The market for radiation oncology treatment planning software is projected to experience robust expansion over the coming years. This market is predicted to reach a value of $3.85 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.9%. Factors contributing to this growth during the forecast period include the rising adoption of precision medicine, the incorporation of AI in clinical decision support systems, greater investment in cancer care infrastructure, the need for fewer treatment side effects, and the broadening use of advanced radiotherapy modalities. Key trends anticipated in the same period encompass AI-assisted treatment planning, 3D and adaptive radiation planning, seamless integration with advanced imaging systems, personalized radiation therapy, and enhanced workflow automation within oncology planning.
Download A Free Sample Report For Comprehensive Market Insights:
Radiation Oncology Treatment Planning Software Market Growth Factors Supporting Long-Term Expansion
The anticipated increase in cancer cases is set to propel the radiation oncology treatment planning software market going forward. This growing prevalence of cancer stems from multiple elements, such as an aging demographic, heightened exposure to various risk factors like tobacco consumption, poor dietary habits, and environmental pollutants, along with progress in early diagnosis and detection tools, and enhanced cancer survival rates. Radiation oncology treatment planning software precisely employs imaging data to pinpoint tumors while safeguarding healthy tissues. It boosts treatment effectiveness and minimizes side effects through the creation of detailed 3D models and the optimization of dose and beam angles. For instance, according to the American Cancer Society, a US-based non-profit organization dedicated to eliminating cancer, there were 108,270 reported cases of skin cancer in January 2024, reflecting a 3.2% increase from the 104,930 cases reported in 2023. Consequently, the increasing incidence of cancer is a key factor driving the growth of the radiation oncology treatment planning software market.
Radiation Oncology Treatment Planning Software Market Segment Analysis Highlighting Growth Areas
The radiation oncology treatment planning software market covered in this report is segmented –
1) By Type: Patient Information Systems, Treatment Planning System
2) By Therapy Type: Stereotactic Radiosurgery (SRS), Three-Dimensional Conformal Radiation Therapy (3D CRT), Brachytherapy, Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiation Therapy (IMRT), Volumetric Modulated Arc Therapy (VMAT), Other Therapy Types
3) By End-User: Hospitals And Physician’s Offices, Research Centers, Government Institutions, Cancer Treatment Centers, Other End-Users
Subsegments:
1) By Patient Information Systems: Patient Registration Systems, Appointment Scheduling Systems, Electronic Health Records (EHR) Integration, Patient Portals, Treatment History Management
2) By Treatment Planning System: 3D Treatment Planning Software, Intensity-Modulated Radiation Therapy (IMRT) Planning, Stereotactic Body Radiation Therapy (SBRT) Planning, Adaptive Radiation Therapy Planning, Brachytherapy Planning Software, Clinical Decision Support Tools
Radiation Oncology Treatment Planning Software Market Strategic Trends: What Is Defining The Next Phase Of Growth?
Major companies within the radiation oncology treatment planning software market are prioritizing the creation of advanced features, including centralized data management, to boost the accuracy of tumor targeting and optimize workflow processes. Centralized data management enhances operational efficiency by consolidating patient information, treatment data, and imaging results onto a single, accessible platform, ensuring streamlined workflows and improved decision-making. For example, in June 2024, Accuray Incorporated, a US-based company focused on radiation therapy solutions, unveiled the Accuray Precision Treatment Planning System (TPS). This system has been approved by the Chinese National Medical Products Administration (NMPA) and efficiently generates and modifies treatment plans, adapting to changes in tumor size, shape, and location. Its real-time modification capabilities increase precision by adjusting for shifts in both tumors and healthy tissues. Integrating effortlessly with the Tomo C system, it offers precise dose control via helical imaging and radiation delivery, with its patented technology ensuring the radiation dose conforms to the tumor while minimizing healthy tissue exposure.
Radiation Oncology Treatment Planning Software Market Leading Companies: Who Holds Significant Market Presence?
Major companies operating in the radiation oncology treatment planning software market are Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Varian Medical Systems Inc., Elekta AB, Brainlab AG, IBA Worldwide SA, Canon Medical Systems Corporation, ViewRay Inc., RaySearch Laboratories AB, Vision RT Ltd., C‑RAD, MVision AI, DOSIsoft SA, Mirada Medical Ltd., Radformation Inc, Prowess Inc, Mevion Medical Systems, Oncology Systems Limited, Spectronic Medical AB, MeVis Medical Solutions AG, Lifeline Software Inc, Sun Nuclear Corporation, Shenzhen Mindray Bio‑Medical Electronics Co Ltd.
Access The Complete Radiation Oncology Treatment Planning Software Market Report:
Radiation Oncology Treatment Planning Software Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in the radiation oncology treatment planning software market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the radiation oncology treatment planning software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.